These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Simultaneous assay of hypoxanthine, xanthine and allopurinol by high-performance liquid chromatography and activation of immobilized xanthine oxidase as an enzyme reactor. Kito M; Tawa R; Takeshima S; Hirose S Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2459-62. PubMed ID: 2605692 [TBL] [Abstract][Full Text] [Related]
45. Specific simultaneous assay of hypoxanthine and xanthine in serum by reversed-phase high-performance liquid chromatography using an immobilized xanthine oxidase reactor. Kito M; Tawa R; Takeshima S; Hirose S J Chromatogr; 1982 Aug; 231(1):183-8. PubMed ID: 6896879 [No Abstract] [Full Text] [Related]
46. Identification of hypoxanthine transport and xanthine oxidase activity in brain capillaries. Betz AL J Neurochem; 1985 Feb; 44(2):574-9. PubMed ID: 3838099 [TBL] [Abstract][Full Text] [Related]
47. Cerebral uric acid, xanthine, and hypoxanthine after ischemia: the effect of allopurinol. Nihei H; Kanemitsu H; Tamura A; Oka H; Sano K Neurosurgery; 1989 Oct; 25(4):613-7. PubMed ID: 2797398 [TBL] [Abstract][Full Text] [Related]
48. Plasma and urinary oxypurines in Lesch-Nyhan patient after allopurinol treatment. Roscioni G; Farnetani MA; Pagani R; Pizzichini M; Marinello E; Porcelli B Adv Exp Med Biol; 1994; 370():357-61. PubMed ID: 7660928 [No Abstract] [Full Text] [Related]
49. Separate enzymatic determination of hypoxanthine and xanthine in human urine. Petersen BB; Jorni J; Jorgensen S Scand J Clin Lab Invest; 1965; 17(5):454-9. PubMed ID: 5839885 [No Abstract] [Full Text] [Related]
51. [Mechanism of exercise-induced hyperuricemia]. Hadano S; Ogasawara M; Ito A Nihon Seirigaku Zasshi; 1987; 49(5):151-9. PubMed ID: 3681743 [TBL] [Abstract][Full Text] [Related]
52. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver]. Mertz DP Fortschr Med; 1983 May; 101(18):851-3. PubMed ID: 6862346 [No Abstract] [Full Text] [Related]
53. Reversed-phase liquid-chromatographic determination of purine compounds in serum applied to studies of hypouricemia. Kojima T; Nishina T; Kitamura M; Kamatani N; Nishioka K Clin Chem; 1986 Feb; 32(2):287-90. PubMed ID: 3943189 [TBL] [Abstract][Full Text] [Related]
54. Renal excretion of purine bases. Effects of probenecid, benzbromarone and pyrazinamide. Yamamoto T; Moriwaki Y; Takahashi S; Hada T; Higashino K Nephron; 1988; 48(2):116-20. PubMed ID: 3344050 [TBL] [Abstract][Full Text] [Related]
55. Induction of profound hypouricemia by a non-sedating thiobarbiturate. Warrell RP; Muindi J; Stevens YW; Isaacs M; Young CW Metabolism; 1989 Jun; 38(6):550-4. PubMed ID: 2725294 [TBL] [Abstract][Full Text] [Related]
56. Uricosuric effect of irtemazole in healthy subjects. Gresser U; Zöllner N Klin Wochenschr; 1989 Oct; 67(19):971-5. PubMed ID: 2615290 [TBL] [Abstract][Full Text] [Related]
57. Xanthine dehydrogenase and purine metabolism in man. With special reference to exercise. Hellsten Y Acta Physiol Scand Suppl; 1994; 621():1-73. PubMed ID: 7942045 [No Abstract] [Full Text] [Related]
58. Renal hypouricemia associated with hyperoxypurinemia due to decreased renal excretion of oxypurines: a new defect in renal purine transport. Kawachi M; Kono N; Mineo I; Kiyokawa H; Nakajima H; Shimizu T; Ono A; Nishimura T; Yorifuji S; Kuwajima M Adv Exp Med Biol; 1991; 309A():239-42. PubMed ID: 1789216 [No Abstract] [Full Text] [Related]
59. An enzymatic spectrophotometric method for the determination of xanthine and hypoxanthine. Klinenberg JR; Goldfinger S; Bradley KH; Seegmiller JE Clin Chem; 1967 Oct; 13(10):834-46. PubMed ID: 6073570 [No Abstract] [Full Text] [Related]
60. Impaired renal excretion of hypoxanthine and xanthine in primary gout. Puig JG; Mateos FA; Jiménez ML; Ramos T; Capitán MC; Gil AA Adv Exp Med Biol; 1989; 253A():269-76. PubMed ID: 2624202 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]